Logo

Berry & Associates Inks Oligo Tech Licensing Deal with Fluorous Technologies

Feb 14, 2005

NEW YORK, Feb. 14 (GenomeWeb News) - Berry & Associates has signed a technology licensing deal with Fluorous Technologies for use of its fluorous synthesis and separation technology, the companies said today.

 

Under the deal, Berry will be able to use the Fluorous Technologies separation technology in a line of fluorous-adapted oligonucleotide synthesis products.

 

Specific terms of the arrangement were not disclosed.

Breaking News
The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.